Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112160 · ClinicalTrials.gov registry record · Phase 2
Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
NCT04112160: Completed Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
NCT04112160 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 125 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04112160, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
Study Summary
This is a prospective randomized double-blind controlled trial assessing the benefits of intramuscular ketorolac before or immediately after office ureteral stent removal.
Primary Outcome
Any unscheduled in-person clinical encounter secondary to renal colic following ureteral stent removal.
Interventions
- DRUG Ketorolac
- DRUG normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2019-08-30 |
| Phase | Phase 2 |
What the finished NCT04112160 record still lists
NCT04112160 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT04112160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04112160 about?
NCT04112160 is a clinical study titled "Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal". This is a prospective randomized double-blind controlled trial assessing the benefits of intramuscular ketorolac before or immediately after office ureteral stent removal.
What is the current status of trial NCT04112160?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2018-06-28. Estimated completion is 2019-08-30.
What interventions are being tested in trial NCT04112160?
The interventions under investigation include: Ketorolac (DRUG), normal saline (DRUG).
Who is sponsoring clinical trial NCT04112160?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04112160's enrollment target sits among peer trials
125 558th of 2000 higher than 1,437 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI